Home
/ Jacobio
/ Competitors

Jacobio Competitors and Similar CompaniesClear all

Jacobio's competitors and similar companies include Kite Pharma, Luye Pharma, United Therapeutics and Achieve Life Sciences.

	Jacobio Jacobio Pharmaceuticals Group (北京加科思新药研发有限公司, formerly known as Jacobio (Cay) Pharmaceuticals) is a pharmaceutical company that provides therapy solutions.	Kite Pharma Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.	Luye Pharma Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.	United Therapeutics United Therapeutics Corporation is a company that develops products for chronic and life-threatening disease treatment.	Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
Founding Date	Founding Date 2015	Founding Date 2009	Founding Date 1994	Founding Date 1996	Founding Date 1995
Type	Type Public	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development life sciences oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare drug development oncology pharma therapy	Tags Healthcare biotech drug development life sciences oncology pharma therapy
Locations	Locations Beijing, CN HQ Beijing, CN Beijing, CN Shanghai, CN Lexington, US	Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more	Locations CN HQ	Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US	Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US
Employees	Employees 2981% decrease	Employees 4,040	Employees 5,270	Employees 1,16819% increase	Employees 148% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 15.8 b	Valuation ($) 172.4 m
Financial
Revenue (est.)	Revenue (est.) ¥63.5m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ¥6.1b (FY, 2023)	Revenue (est.) $2.3b (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥35.2m (FY, 2023)	Cost of goods N/A	Cost of goods ¥1.2b (FY, 2023)	Cost of goods $257.5m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit ¥35.8m (FY, 2023)	Gross profit N/A	Gross profit ¥5.1b (FY, 2023)	Gross profit $2.1b (FY, 2023)	Gross profit N/A
Net income	Net income (¥359.1m) (FY, 2023)	Net income N/A	Net income ¥539.1m (FY, 2023)	Net income $984.8m (FY, 2023)	Net income ($29.8m) (FY, 2023)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 85.3m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 10m